11/30/2021  10:46:21 AM Chg. -0.260 Volume Bid10:47:22 AM Ask10:47:22 AM Market Capitalization Dividend Y. P/E Ratio
18.020EUR -1.42% 23,801
Turnover: 427,831.820
17.980Bid Size: 1,400 18.020Ask Size: 1,400 89.06 bill.EUR - -

Business description

GSK is a british pharmaceutical and healthcare company. GSK manufactures drugs and vaccines for major disease areas such as asthma, cancer, infections, diabetes, digestive and mental health conditions. Many medicines were historically discovered or developed at GSK and its predecessor companies and are now sold as generics.

Management board & Supervisory board

Emma Walmsley
Management board
Iain Mackay, Brian McNamara, David Redfern, Deborah Waterhouse, Diana Conrad, Dr. Hal Barron, James Ford, Karenann Terrell, Luke Miels, Phil Thomson, Regis Simard, Roger Connor, Sally Jackson
Supervisory board
Jonathan Symonds, Charles Bancroft, Dr Harry C. Dietz (ab 1.01.2022), Dr. Anne Beal, Dr. Hal Barron, Dr. Jesse Goodman, Dr. Laurie Glimcher, Dr. Vivienne Cox, Emma Walmsley, Iain Mackay, Lynn Elsenhans, Manvinder Singh Banga, Urs Rohner

Company data

Name: GlaxoSmithKline PLC
Address: 980 Great West Road,UK-Brentford, Middlesex TW8 9GS
Phone: +44-20-8047-5000
Fax: -
E-mail: -
Internet: www.gsk.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 83.48%
IPO date: -

Investor relations

Name: Nick Stone
IR phone: -
IR Fax: -
IR e-mail: GSK.Investor-Relations@gsk.com

Company calendar

CW 3 | 1/13/2022 Dividend Payment
CW 7 | 2/9/2022 4th Quarter/Annual Report
CW 15 | 4/7/2022 Dividend Payment

Main Shareholders

BlackRock, Inc.
The Capital Group Companies, Inc.
Dodge & Cox